135 related articles for article (PubMed ID: 8515719)
1. Interferon beta-1B for multiple sclerosis.
Med Lett Drugs Ther; 1993 Jul; 35(900):61-2. PubMed ID: 8515719
[No Abstract] [Full Text] [Related]
2. Beta interferons for multiple sclerosis.
Med Lett Drugs Ther; 2002 Oct; 44(1141):88-9. PubMed ID: 12381969
[No Abstract] [Full Text] [Related]
3. Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis.
Horowski R; Stürzebecher CS; Kapp JF
Funct Neurol; 2001; 16(2):117-28. PubMed ID: 11495417
[No Abstract] [Full Text] [Related]
4. Interferon-beta 1b: new hope for multiple sclerosis.
Holdcroft C
Nurse Pract; 1994 Jan; 19(1):6. PubMed ID: 8139804
[No Abstract] [Full Text] [Related]
5. Use of interferon-beta in the treatment of multiple sclerosis.
Derwenskus J; Lublin FD
Adv Neurol; 2006; 98():257-71. PubMed ID: 16400838
[No Abstract] [Full Text] [Related]
6. [Interferon beta-1b now also for the relapsing progressive form of multiple sclerosis?].
Polman CH
Ned Tijdschr Geneeskd; 1999 Apr; 143(15):815-7. PubMed ID: 10347645
[No Abstract] [Full Text] [Related]
7. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
Schwid SR; Panitch HS
Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of relapsing-remitting multiple sclerosis with interferon beta type 1-b].
Bencsik K; Rajda C; Klivényi P; Járdánházy T; Török M; Vécsei L
Orv Hetil; 1999 Apr; 140(14):763-6. PubMed ID: 10224846
[TBL] [Abstract][Full Text] [Related]
9. Advancing treatment with interferon beta-1b (Betaferon/Betaseron) in the next decade--thinking beyond the standard dose.
Cook SD
J Neurol; 2003 Dec; 250 Suppl 4():IV15-20. PubMed ID: 14712397
[TBL] [Abstract][Full Text] [Related]
10. Treatment of multiple sclerosis with interferon beta 1b.
Dhib-Jalbut S; McFarland HF
Baillieres Clin Neurol; 1997 Oct; 6(3):467-80. PubMed ID: 10101584
[TBL] [Abstract][Full Text] [Related]
11. Dose and frequency of interferon treatment matter--INCOMIN and OPTIMS.
Durelli L
J Neurol; 2003 Dec; 250 Suppl 4():IV9-IV14. PubMed ID: 14712396
[TBL] [Abstract][Full Text] [Related]
12. Interferon beta-1A: new preparation. A short-term impact on the course of multiple sclerosis.
Prescrire Int; 1998 Oct; 7(37):142-3. PubMed ID: 10915418
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
[TBL] [Abstract][Full Text] [Related]
14. [High doses of interferon in the treatment of multiple sclerosis].
Muñoz D
Rev Neurol; 2001 May 1-15; 32(9):899. PubMed ID: 11424041
[No Abstract] [Full Text] [Related]
15. [Interferon beta-1b retinopathy during a treatment for multiple sclerosis].
Sommer S; Sablon JC; Zaoui M; Rozot P; Hosni A
J Fr Ophtalmol; 2001 May; 24(5):509-12. PubMed ID: 11397988
[TBL] [Abstract][Full Text] [Related]
16. [Interferon beta-1b in multiple sclerosis. Basic therapy in intermittent and secondary progressive course].
Nervenarzt; 1999 Nov; 70(11 Suppl Basisthera):1-4. PubMed ID: 10603601
[No Abstract] [Full Text] [Related]
17. Interferon-beta1b in multiple sclerosis.
Buttmann M; Rieckmann P
Expert Rev Neurother; 2007 Mar; 7(3):227-39. PubMed ID: 17341170
[TBL] [Abstract][Full Text] [Related]
18. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
Leppert D; Waubant E; Bürk MR; Oksenberg JR; Hauser SL
Ann Neurol; 1996 Dec; 40(6):846-52. PubMed ID: 9007089
[TBL] [Abstract][Full Text] [Related]
19. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
Nakamura Y; Kawachi Y; Furuta J; Otsuka F
Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
[TBL] [Abstract][Full Text] [Related]
20. [10 years of interferon treatment in multiple sclerosis. Does the future belong to high-dose therapy?].
MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579501
[No Abstract] [Full Text] [Related]
[Next] [New Search]
